相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。APP Maturation and Intracellular Localization Are Controlled by a Specific Inhibitor of 37/67 kDa Laminin-1 Receptor in Neuronal Cells
Antaripa Bhattacharya et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Progression of Alzheimer's disease and effect of scFv-h3D6 immunotherapy in the 3xTg-AD mouse model: An in vivo longitudinal study using Magnetic Resonance Imaging and Spectroscopy
J. Guell-Bosch et al.
NMR IN BIOMEDICINE (2020)
New Insights into the Molecular Bases of Familial Alzheimer's Disease
Valeria D'Argenio et al.
JOURNAL OF PERSONALIZED MEDICINE (2020)
Retire statistical significance
Valentin Amrhein et al.
NATURE (2019)
Treatment with scFv-h3D6 Prevented Neuronal Loss and Improved Spatial Memory in Young 3xTg-AD Mice by Reducing the Intracellular Amyloid-β Burden
Gisela Esquerda-Canalsa et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Pharmacokinetic parameters and mechanism of action of an efficient anti-Aβ single chain antibody fragment
Gisela Esquerda-Canals et al.
PLOS ONE (2019)
Amyloid-β immunotherapy for alzheimer disease: Is it now a long shot?
Francesco Panza et al.
ANNALS OF NEUROLOGY (2019)
Differential effects of apoE and apoJ mimetic peptides on the action of an anti-Aβ scFv in 3xTg-AD mice
Laia Montoliu-Gaya et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Phos-tau peptide immunization of amyloid-tg-mice reduced non-mutant phos-tau pathology, improved cognition and reduced amyloid plaques
Sandrine Benhamron et al.
EXPERIMENTAL NEUROLOGY (2018)
Differences Between Women and Men in Incidence Rates of Dementia and Alzheimer's Disease
Christopher R. Beam et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Aβ-oligomer uptake and the resulting inflammatory response in adult human astrocytes are precluded by an anti-Aβ single chain variable fragment in combination with an apoE mimetic peptide
Laia Montoliu-Gaya et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2018)
Tau-targeting therapies for Alzheimer disease
Erin E. Congdon et al.
NATURE REVIEWS NEUROLOGY (2018)
Efficient clearence of Aβ protofibrils in AβPP-transgenic mice treated with a brain-penetrating bifunctional antibody
Stina Syvanen et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model
Krystal Herline et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Sex Differences in Healthspan Predict Lifespan in the 3xTg-AD Mouse Model of Alzheimer's Disease
Alice E. Kane et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Evidence of intraneuronal A accumulation preceding tau pathology in the entorhinal cortex
Lindsay A. Welikovitch et al.
ACTA NEUROPATHOLOGICA (2018)
Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases
Daniela Sarnataro
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The Role of Glial Cells and Synapse Loss in Mouse Models of Alzheimer's Disease
Stephanie Ziegler-Waldkirch et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Active full-length DNA Aβ42 immunization in 3xTg-AD mice reduces not only amyloid deposition but also tau pathology
Roger N. Rosenberg et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Alzheimer's disease: experimental models and reality
Eleanor Drummond et al.
ACTA NEUROPATHOLOGICA (2017)
An Intracellular Amyloid-β/AβPP Epitope Correlates with Neurodegeneration in those Neuronal Populations Early Involved in Alzheimer's Disease
Gisela Esquerda-Canals et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Immune hyperreactivity of Ab plaque-associated microglia in Alzheimer's disease
Zhuoran Yin et al.
NEUROBIOLOGY OF AGING (2017)
Prevalence and incidence of Alzheimer's disease in Europe: A meta -analysis
H. Niu et al.
NEUROLOGIA (2017)
Tau passive immunization inhibits not only tau but also Aβ pathology
Chun-ling Dai et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Interleukin33 deficiency causes tau abnormality and neurodegeneration with Alzheimer-like symptoms in aged mice
C. Carlock et al.
TRANSLATIONAL PSYCHIATRY (2017)
Production of an anti-Aβ antibody fragment in Pichia pastoris and in vitro and in vivo validation of its therapeutic effect
Laia Montoliu-Gaya et al.
PLOS ONE (2017)
Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides
Laia Montoliu-Gaya et al.
PLOS ONE (2017)
Towards the improvement in stability of an anti-Aβ single-chain variable fragment, scFv-h3D6, as a way to enhance its therapeutic potential
Laia Montoliu-Gaya et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2017)
Intracellular A beta and its Pathological Role in Alzheimer's Disease: Lessons from the Cellular to Animal Model
Lina Ji et al.
CURRENT ALZHEIMER RESEARCH (2016)
CSF, blood-brain barrier, and brain drug delivery
William M. Pardridge
EXPERT OPINION ON DRUG DELIVERY (2016)
Aβ-Immunotherapeutic strategies: a wide range of approaches for Alzheimer's disease treatment
Laia Montoliu-Gaya et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2016)
TREM2 variants: new keys to decipher Alzheimer disease pathogenesis
Marco Colonna et al.
NATURE REVIEWS NEUROSCIENCE (2016)
IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline
Amy K. Y. Fu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Soyon Hong et al.
SCIENCE (2016)
Tau Protein Mediates APP Intracellular Domain (AICD)-Induced Alzheimer's-Like Pathological Features in Mice
Kaushik Ghosal et al.
PLOS ONE (2016)
Dealing with Danger in the CNS: The Response of the Immune System to Injury
Sachin P. Gadani et al.
NEURON (2015)
Tau Oligomers: The Toxic Player at Synapses in Alzheimer's Disease
Marcos J. Guerrero-Munoz et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
Christiane Reitz et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Alzheimer's Disease: Evidence for the Expression of Interleukin-33 and Its Receptor ST2 in the Brain
Zhi Xiong et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Abundance of Aβ5-x x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease
Erika Avendano Guzman et al.
MOLECULAR NEURODEGENERATION (2014)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
New roles for Fc receptors in neurodegeneration-the impact on lmmunotherapy for Alzheimer's Disease
James P. Fuller et al.
FRONTIERS IN NEUROSCIENCE (2014)
Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing A deposition and tau pathology in 3xTg-AD mice
Suhail Rasool et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Elongation of the C-terminal domain of an anti-amyloid β single-chain variable fragment increases its thermodynamic stability and decreases its aggregation tendency
Geovanny Rivera-Hernandez et al.
MABS (2013)
Loss of deep cerebellar nuclei neurons in the 3xTg-AD mice and protection by an anti-amyloid β antibody fragment
Gisela Esquerda-Canals et al.
MABS (2013)
Early intervention in the 3xTg-AD mice with an amyloid β-antibody fragment ameliorates first hallmarks of alzheimer disease
Lydia Gimenez-Llort et al.
MABS (2013)
TREM2 Variants in Alzheimer's Disease
Rita Guerreiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Engineered antibody approaches for Alzheimer's disease immunotherapy
Remy Robert et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease
Kaj Blennow et al.
ARCHIVES OF NEUROLOGY (2012)
The immunology of neurodegeneration
Eva Czirr et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
Reisa Sperling et al.
LANCET NEUROLOGY (2012)
Intraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibody
Katherine L. Youmans et al.
MOLECULAR NEURODEGENERATION (2012)
An anti-Aβ (amyloid β) single-chain variable fragment prevents amyloid fibril formation and cytotoxicity by withdrawing Aβ oligomers from the amyloid pathway
Marta Marin-Argany et al.
BIOCHEMICAL JOURNAL (2011)
Monoclonal antibodies against β-amyloid (Aβ) for the treatment of Alzheimer's disease: the Aβ target at a crossroads
Francesco Panza et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
Sex differences in β-amyloid accumulation in 3xTg-AD mice: Role of neonatal sex steroid hormone exposure
Jenna C. Carroll et al.
BRAIN RESEARCH (2010)
Bapineuzumab
Geoffrey A. Kerchner et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's disease
Francesco Panza et al.
IMMUNOTHERAPY (2010)
Clearance of Amyloid-beta Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimer's Disease
R. Deane et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain
Kaushik Ghosal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Immunotherapy reduces vascular amyloid-β in PDAPP mice
Sally Schroeter et al.
JOURNAL OF NEUROSCIENCE (2008)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice
LM Billings et al.
NEURON (2005)
Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice
Michael T. Heneka et al.
JOURNAL OF NEUROINFLAMMATION (2005)
Triple-transgenic model of Alzheimer's disease with plaques and tangles:: Intracellular Aβ and synaptic dysfunction
S Oddo et al.
NEURON (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
分享论文
